Analyzing plaque samples to understand sugar intake effects in Alaska Native children
Microbiome Analysis of Plaque Samples from a Community-Based Socio-behavioral RCT to Reduce Sugared Fruit Drinks in Alaska Native Children
['FUNDING_R03'] · UNIVERSITY OF WASHINGTON · NIH-11064800
This study is looking at how cutting back on sugary fruit drinks can affect the mouth bacteria of Alaska Native children, and it’s for families who want to learn more about how their kids' diet can improve their oral health.
Quick facts
| Phase | ['FUNDING_R03'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11064800 on ClinicalTrials.gov |
What this research studies
This research investigates the impact of reducing sugared fruit drinks on the oral microbiome of Alaska Native children. It builds on a previous community-based intervention that educated families about the harms of sugary drinks and promoted healthier alternatives. The study will analyze plaque samples collected from children over a six-month period to assess changes in their microbiome related to sugar intake. By examining these samples, researchers aim to uncover important relationships between diet and oral health in this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are Alaska Native children aged 1 to 10 years who participated in the previous intervention.
Not a fit: Patients outside the age range of 1 to 10 years or those not belonging to Alaska Native communities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved oral health outcomes for Alaska Native children by informing better dietary practices.
How similar studies have performed: Previous research has shown success in community-based interventions targeting dietary changes to improve health outcomes, making this approach promising.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHI, DONALD LESLIE — UNIVERSITY OF WASHINGTON
- Study coordinator: CHI, DONALD LESLIE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.